par Fortin, Geneviève;Yurchenko, K;Collette, Catherine;Rubio, M;Villani, Alexandra-Chloé;Bitton, A;Sarfati, Marika;Franchimont, Denis
Référence Clinical and experimental immunology, 156, 1, page (161-171)
Publication Publié, 2009-04
Référence Clinical and experimental immunology, 156, 1, page (161-171)
Publication Publié, 2009-04
Article révisé par les pairs
Titre: |
|
Auteur: | Fortin, Geneviève; Yurchenko, K; Collette, Catherine; Rubio, M; Villani, Alexandra-Chloé; Bitton, A; Sarfati, Marika; Franchimont, Denis |
Informations sur la publication: | Clinical and experimental immunology, 156, 1, page (161-171) |
Statut de publication: | Publié, 2009-04 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Animals |
CD4-Positive T-Lymphocytes -- drug effects | |
Carnitine -- pharmacology | |
Carnitine -- therapeutic use | |
Cells, Cultured | |
Colitis -- chemically induced | |
Colitis -- prevention & control | |
Cytokines -- biosynthesis | |
Dendritic Cells -- drug effects | |
Dietary Supplements | |
Disease Models, Animal | |
Dose-Response Relationship, Immunologic | |
Drug Evaluation, Preclinical -- methods | |
Immunosuppressive Agents -- pharmacology | |
Immunosuppressive Agents -- therapeutic use | |
Inflammation Mediators -- metabolism | |
Lipopolysaccharides -- immunology | |
Lymphocyte Activation | |
Macrophages -- drug effects | |
Male | |
Mice | |
Mice, Inbred BALB C | |
Organic Cation Transport Proteins -- physiology | |
Spleen -- drug effects | |
Trinitrobenzenesulfonic Acid | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
FLWIN | |
Langue: | Anglais |
Identificateurs: | urn:issn:0009-9104 |
info:doi/10.1111/j.1365-2249.2009.03879.x | |
info:pii/CEI3879 | |
info:pmid/19175620 |